Black Rock Inc. Acadia Pharmaceuticals Inc Put Options Transaction History
Black Rock Inc.
- $4.23 Trillion
- Q1 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding ACAD
# of Institutions
299Shares Held
158MCall Options Held
1.88MPut Options Held
688K-
Baker Bros. Advisors LP New York, NY42.9MShares$697 Million10.04% of portfolio
-
Rtw Investments, LP New York, NY13.8MShares$225 Million4.1% of portfolio
-
Vanguard Group Inc Valley Forge, PA13.3MShares$216 Million0.0% of portfolio
-
State Street Corp Boston, MA6MShares$97.5 Million0.01% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA5.99MShares$97.4 Million3.16% of portfolio
About ACADIA PHARMACEUTICALS INC
- Ticker ACAD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 161,843,008
- Market Cap $2.63B
- Description
- ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...